Exosome Diagnostic and Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: ED8A4C09B96BEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Exosome Diagnostic and Therapeutics in Global, including the following market information:

Global Exosome Diagnostic and Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Exosome Diagnostic and Therapeutics market was valued at 101.1 million in 2021 and is projected to reach US$ 760.6 million by 2028, at a CAGR of 33.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Instrument Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Exosome Diagnostic and Therapeutics include Thermo Fisher, NanoSomix, NX PHARMAGEN, Malvern, Capricor, Exosome, Exiqon, System Biosciences and Aegle and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Exosome Diagnostic and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Exosome Diagnostic and Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Exosome Diagnostic and Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Instrument
• Software
• Reagents and Kits

Global Exosome Diagnostic and Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Exosome Diagnostic and Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Cancer Institutes
• Diagnostic Centres
• Others

Global Exosome Diagnostic and Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Exosome Diagnostic and Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Exosome Diagnostic and Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Exosome Diagnostic and Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher
• NanoSomix
• NX PHARMAGEN
• Malvern
• Capricor
• Exosome
• Exiqon
• System Biosciences
• Aegle
• AMS

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Exosome Diagnostic and Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Exosome Diagnostic and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Exosome Diagnostic and Therapeutics Market Size: 2021 VS 2028
2.2 Global Exosome Diagnostic and Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Exosome Diagnostic and Therapeutics Players in Global Market
3.2 Top Global Exosome Diagnostic and Therapeutics Companies Ranked by Revenue
3.3 Global Exosome Diagnostic and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Exosome Diagnostic and Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Exosome Diagnostic and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Exosome Diagnostic and Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Exosome Diagnostic and Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Exosome Diagnostic and Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Exosome Diagnostic and Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Instrument
  4.1.3 Software
  4.1.4 Reagents and Kits
4.2 By Type - Global Exosome Diagnostic and Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Exosome Diagnostic and Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Exosome Diagnostic and Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Exosome Diagnostic and Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Cancer Institutes
  5.1.4 Diagnostic Centres
  5.1.5 Others
5.2 By Application - Global Exosome Diagnostic and Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Exosome Diagnostic and Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Exosome Diagnostic and Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Exosome Diagnostic and Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Exosome Diagnostic and Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Exosome Diagnostic and Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Exosome Diagnostic and Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Exosome Diagnostic and Therapeutics Revenue, 2017-2028
  6.3.2 US Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.3.3 Canada Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Exosome Diagnostic and Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Exosome Diagnostic and Therapeutics Revenue, 2017-2028
  6.4.2 Germany Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.4.3 France Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.4.5 Italy Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.4.6 Russia Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Exosome Diagnostic and Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Exosome Diagnostic and Therapeutics Revenue, 2017-2028
  6.5.2 China Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.5.3 Japan Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.5.6 India Exosome Diagnostic and Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Exosome Diagnostic and Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Exosome Diagnostic and Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Exosome Diagnostic and Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.7.3 Israel Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Exosome Diagnostic and Therapeutics Market Size, 2017-2028
  6.7.5 UAE Exosome Diagnostic and Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher
  7.1.1 Thermo Fisher Corporate Summary
  7.1.2 Thermo Fisher Business Overview
  7.1.3 Thermo Fisher Exosome Diagnostic and Therapeutics Major Product Offerings
  7.1.4 Thermo Fisher Exosome Diagnostic and Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Key News
7.2 NanoSomix
  7.2.1 NanoSomix Corporate Summary
  7.2.2 NanoSomix Business Overview
  7.2.3 NanoSomix Exosome Diagnostic and Therapeutics Major Product Offerings
  7.2.4 NanoSomix Exosome Diagnostic and Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 NanoSomix Key News
7.3 NX PHARMAGEN
  7.3.1 NX PHARMAGEN Corporate Summary
  7.3.2 NX PHARMAGEN Business Overview
  7.3.3 NX PHARMAGEN Exosome Diagnostic and Therapeutics Major Product Offerings
  7.3.4 NX PHARMAGEN Exosome Diagnostic and Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 NX PHARMAGEN Key News
7.4 Malvern
  7.4.1 Malvern Corporate Summary
  7.4.2 Malvern Business Overview
  7.4.3 Malvern Exosome Diagnostic and Therapeutics Major Product Offerings
  7.4.4 Malvern Exosome Diagnostic and Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Malvern Key News
7.5 Capricor
  7.5.1 Capricor Corporate Summary
  7.5.2 Capricor Business Overview
  7.5.3 Capricor Exosome Diagnostic and Therapeutics Major Product Offerings
  7.5.4 Capricor Exosome Diagnostic and Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Capricor Key News
7.6 Exosome
  7.6.1 Exosome Corporate Summary
  7.6.2 Exosome Business Overview
  7.6.3 Exosome Exosome Diagnostic and Therapeutics Major Product Offerings
  7.6.4 Exosome Exosome Diagnostic and Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Exosome Key News
7.7 Exiqon
  7.7.1 Exiqon Corporate Summary
  7.7.2 Exiqon Business Overview
  7.7.3 Exiqon Exosome Diagnostic and Therapeutics Major Product Offerings
  7.7.4 Exiqon Exosome Diagnostic and Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Exiqon Key News
7.8 System Biosciences
  7.8.1 System Biosciences Corporate Summary
  7.8.2 System Biosciences Business Overview
  7.8.3 System Biosciences Exosome Diagnostic and Therapeutics Major Product Offerings
  7.8.4 System Biosciences Exosome Diagnostic and Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 System Biosciences Key News
7.9 Aegle
  7.9.1 Aegle Corporate Summary
  7.9.2 Aegle Business Overview
  7.9.3 Aegle Exosome Diagnostic and Therapeutics Major Product Offerings
  7.9.4 Aegle Exosome Diagnostic and Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Aegle Key News
7.10 AMS
  7.10.1 AMS Corporate Summary
  7.10.2 AMS Business Overview
  7.10.3 AMS Exosome Diagnostic and Therapeutics Major Product Offerings
  7.10.4 AMS Exosome Diagnostic and Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 AMS Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Exosome Diagnostic and Therapeutics Market Opportunities & Trends in Global Market
Table 2. Exosome Diagnostic and Therapeutics Market Drivers in Global Market
Table 3. Exosome Diagnostic and Therapeutics Market Restraints in Global Market
Table 4. Key Players of Exosome Diagnostic and Therapeutics in Global Market
Table 5. Top Exosome Diagnostic and Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Exosome Diagnostic and Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Exosome Diagnostic and Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Exosome Diagnostic and Therapeutics Product Type
Table 9. List of Global Tier 1 Exosome Diagnostic and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Exosome Diagnostic and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Exosome Diagnostic and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Exosome Diagnostic and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Exosome Diagnostic and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Exosome Diagnostic and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Exosome Diagnostic and Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Exosome Diagnostic and Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Corporate Summary
Table 31. Thermo Fisher Exosome Diagnostic and Therapeutics Product Offerings
Table 32. Thermo Fisher Exosome Diagnostic and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. NanoSomix Corporate Summary
Table 34. NanoSomix Exosome Diagnostic and Therapeutics Product Offerings
Table 35. NanoSomix Exosome Diagnostic and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. NX PHARMAGEN Corporate Summary
Table 37. NX PHARMAGEN Exosome Diagnostic and Therapeutics Product Offerings
Table 38. NX PHARMAGEN Exosome Diagnostic and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Malvern Corporate Summary
Table 40. Malvern Exosome Diagnostic and Therapeutics Product Offerings
Table 41. Malvern Exosome Diagnostic and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Capricor Corporate Summary
Table 43. Capricor Exosome Diagnostic and Therapeutics Product Offerings
Table 44. Capricor Exosome Diagnostic and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Exosome Corporate Summary
Table 46. Exosome Exosome Diagnostic and Therapeutics Product Offerings
Table 47. Exosome Exosome Diagnostic and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Exiqon Corporate Summary
Table 49. Exiqon Exosome Diagnostic and Therapeutics Product Offerings
Table 50. Exiqon Exosome Diagnostic and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. System Biosciences Corporate Summary
Table 52. System Biosciences Exosome Diagnostic and Therapeutics Product Offerings
Table 53. System Biosciences Exosome Diagnostic and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Aegle Corporate Summary
Table 55. Aegle Exosome Diagnostic and Therapeutics Product Offerings
Table 56. Aegle Exosome Diagnostic and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. AMS Corporate Summary
Table 58. AMS Exosome Diagnostic and Therapeutics Product Offerings
Table 59. AMS Exosome Diagnostic and Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Exosome Diagnostic and Therapeutics Segment by Type in 2021
Figure 2. Exosome Diagnostic and Therapeutics Segment by Application in 2021
Figure 3. Global Exosome Diagnostic and Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Exosome Diagnostic and Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Exosome Diagnostic and Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Exosome Diagnostic and Therapeutics Revenue in 2021
Figure 8. By Type - Global Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Exosome Diagnostic and Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Exosome Diagnostic and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Exosome Diagnostic and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. NanoSomix Exosome Diagnostic and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. NX PHARMAGEN Exosome Diagnostic and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Malvern Exosome Diagnostic and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Capricor Exosome Diagnostic and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Exosome Exosome Diagnostic and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Exiqon Exosome Diagnostic and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. System Biosciences Exosome Diagnostic and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Aegle Exosome Diagnostic and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. AMS Exosome Diagnostic and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)